Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Chitose Ogawa, MD, Atsushi Manabe, MD PhD, Hiroaki Goto, MD PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD PhD, Keitaro Fukushima, MD PhD, Ken-ichiro Watanabe, MD PhD, Keizo Horibe, MD, Atsushi Kikuta, MD PhD, Mitsuma Hamada, PhD, Akira Ohara, MD PhD

Blood (2014) 124 (21): 3657.

https://doi.org/10.1182/blood.V124.21.3657.3657

Published: 2014

Journal Articles

CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)

Norio Shiba, Daisuke Hasegawa, Myoung-ja Park, Chisato Murata, Aiko Sato-Otsubo, Chitose Ogawa, Atsushi Manabe, Hirokazu Arakawa, Seishi Ogawa, Yasuhide Hayashi

Blood (2012) 119 (11): 2612–2614.

https://doi.org/10.1182/blood-2011-02-333435

Published: 2012

Journal Articles

Successful Reduction of Cranial Irradiation in Children with B Cell Precursor Acute Lymphoblastic Leukemia(ALL) through Four Consecutive ALL Studies: Long-Term Follow-up of ALL in Tokyo Children’s Cancer Study Group (TCCSG) L89-12, 92-13, 95-14 and 99-15 Studies.

Chitose Ogawa, Akira Ohara, MD, Atsushi Manabe, MD, PhD, Akira Kikuchi, MD., PhD, Katsuyoshi Koh, Daisuke Tomizawa, Junya Fujimura, Hiroyasu Inoue, Syosuke Sunami, Eizaburo Ishii, Masaaki Shiohara, Tetsuya Mori, Hiroyuki Takahashi, Yasuhide Hayashi, Ryoji Hanada, Masahiro Tsuchida

Blood (2008) 112 (11): 913.

https://doi.org/10.1182/blood.V112.11.913.913

Published: 2008

Journal Articles

Significance of Initial Lumbar Puncture on Day8 of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia: The Results from the Tokyo Children’s Cancer Study Group L99-15 Protocol.

Daisuke Hasegawa, Atsushi Manabe, Akira Ohara, MD, Katsuyoshi Koh, MD., PhD, Chitose Ogawa, Ryoji Hanada, Masahiro Tsuchida

Blood (2008) 112 (11): 914.

https://doi.org/10.1182/blood.V112.11.914.914

Published: 2008

Journal Articles

Prognostic Factors for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL): A Report from Tokyo Children’s Cancer Study Group (TCCSG) Study L95-14 and L-99-15.

Chitose Ogawa, MD, Akira Ohara, MD, Atsushi Manabe, MD, Katsuyoshi Koh, MD, Takashi Kaneko, MD, Hiroaki Goto, MD, Setsuo Ota, MD, Ryoji Hanada, MD, Masahiro Tsuchida, MD

Blood (2006) 108 (11): 1884.

https://doi.org/10.1182/blood.V108.11.1884.1884

Published: 2006

Journal Articles

Treatment Outcome of Discontinued L-Asparaginase in Children with Standard-Risk Acute Lymphoblastic Leukemia: Tokyo Children’s Cancer Study Group (TCCSG) Study L99-15.

Chitose Ogawa, MD, Akira Ohara, MD, Atsushi Manabe, MD, Ryoji Hanada, MD, Hiroyuki Takahashi, MD, Katsuyoshi Koh, MD, Michiko Kajiwara, MD, Miho Maeda, MD, Kenichi Sugita, MD, Akira Kikuchi, MD, Keiichi Isoyama, MD, Yasushi Noguchi, MD, Masahiro Saito, MD, Setsuo Ota, MD, Takashi Fukushima, MD, Hiromasa Yabe, MD, Yasunori Toyoda, MD, Tomohiro Saito, MD, MPH, Mahiro Tsuchida, MD

Blood (2005) 106 (11): 878.

https://doi.org/10.1182/blood.V106.11.878.878

Published: 2005

NARROW

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)

Successful Reduction of Cranial Irradiation in Children with B Cell Precursor Acute Lymphoblastic Leukemia(ALL) through Four Consecutive ALL Studies: Long-Term Follow-up of ALL in Tokyo Children’s Cancer Study Group (TCCSG) L89-12, 92-13, 95-14 and 99-15 Studies.

Significance of Initial Lumbar Puncture on Day8 of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia: The Results from the Tokyo Children’s Cancer Study Group L99-15 Protocol.

Prognostic Factors for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL): A Report from Tokyo Children’s Cancer Study Group (TCCSG) Study L95-14 and L-99-15.

Treatment Outcome of Discontinued L-Asparaginase in Children with Standard-Risk Acute Lymphoblastic Leukemia: Tokyo Children’s Cancer Study Group (TCCSG) Study L99-15.

Email alerts

ASH Publications

American Society of Hematology

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)

Successful Reduction of Cranial Irradiation in Children with B Cell Precursor Acute Lymphoblastic Leukemia(ALL) through Four Consecutive ALL Studies: Long-Term Follow-up of ALL in Tokyo Children’s Cancer Study Group (TCCSG) L89-12, 92-13, 95-14 and 99-15 Studies.

Significance of Initial Lumbar Puncture on Day8 of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia: The Results from the Tokyo Children’s Cancer Study Group L99-15 Protocol.

Prognostic Factors for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL): A Report from Tokyo Children’s Cancer Study Group (TCCSG) Study L95-14 and L-99-15.

Treatment Outcome of Discontinued L-Asparaginase in Children with Standard-Risk Acute Lymphoblastic Leukemia: Tokyo Children’s Cancer Study Group (TCCSG) Study L99-15.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only